Ramón Campos-Olivas Selected Research

Ramón Campos-Olivas Research Topics

7	Neoplasms (Cancer) 01/2017 - 12/2008
1	Fibrosis (Cirrhosis) 01/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Inflammation (Inflammations) 01/2017
1	Carcinogenesis 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Breast Neoplasms (Breast Cancer) 10/2015
1	Glioma (Gliomas) 01/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2012
1	Astrocytoma (Pilocytic Astrocytoma) 01/2012
1	Neoplasm Metastasis (Metastasis) 10/2011
1	Wasting Syndrome (Wasting Disease) 03/2007

2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2007
2	Phosphotransferases (Kinase)IBA 04/2016 - 10/2011
1	ChromatinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	bile acid binding proteinsIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	CholesterolIBA 01/2017
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	InterferonsIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016
1	Amino Acids FDA Link 04/2016
1	Imatinib Mesylate (Gleevec)FDA Link 04/2016
1	Pharmaceutical PreparationsIBA 04/2016
1	PoisonsIBA 10/2015
1	GlycolipidsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	GlycosidesIBA 01/2013
1	Protons (Proton)IBA 01/2013
1	Taurine FDA Link 01/2013
1	GD1b gangliosideIBA 01/2012
1	GangliosidesIBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2012
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2012
1	GlycosphingolipidsIBA 01/2012
1	neurostatinIBA 01/2012
1	Sialic AcidsIBA 01/2012
1	src-Family KinasesIBA 10/2011
1	A-Form DNA (A-DNA)IBA 12/2008
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2008
1	EndonucleasesIBA 03/2007
1	SolutionsIBA 03/2007

1	Therapeutics 10/2015